22 January 2009

Luanda — The director general of the Angolan medicines company
(Angomédica), José Luís Pascoal, Thursday in Luanda spoke of the need
for regulation of imports of medicines in the country.

"We are in a society in which the production of medicines is still
incipient, but there are several importers, " he said.

The director was speaking to the press alongside a talk on "Medicine
quality control", on the occasion of the relaunch of the medicine
control laboratory, on the premises of Angomedica.

Counterfeiting of medicines is a global problem the World Health
Organisation (WHO) has been warning the states to be prepared to
regulate and counter this tendency.

José Pascoal explained that the laboratory will offer services of
testing of the raw material Angomedica will use in the various processes
of production of medicines.

The source said the plant will start the production of medicines between
the second and third quarter of this year.

Angomédica has as its purpose the production, purchase and trade of
medicines, raw materials and products quality control.

Functioning since February 1992, Angomedica has three plants, one of
which in Luanda and the other in central Benguela province.